Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kanellopoulos, P.
Right arrow Articles by Tzioufas, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanellopoulos, P.
Right arrow Articles by Tzioufas, A. G.
Related Collections
Right arrow Myositis and Muscle Disease
Right arrow Sjogren's Syndrome
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2002; 41: 440-444
© 2002 British Society for Rheumatology


Original Papers

Primary Sjögren's syndrome associated with inclusion body myositis

P. Kanellopoulos, C. Baltoyiannis1 and A. G. Tzioufas

Department of Pathophysiology and
1 Department of Neurology, School of Medicine, University of Athens, Greece

Objective. To describe three new patients with inclusion body myositis (IBM) associated with primary Sjögren's syndrome (pSS) and summarize the clinical and serological picture for all six patients reported so far.

Patients and methods. Three out of 518 (0.6%) pSS patients followed in our department over a period of 15 yr (1985–2000) also presented IBM. The diagnosis was based on histological criteria. Previous reports described four more patients with IBM associated with pSS. Five out of six were females; the mean age of IBM onset was 53.3±14.0 yr and the disease duration 8.0+5.8 yr.

Results. Four out of six patients presented IBM several years after the onset of pSS. Four out of six patients presented extraglandular manifestations, such as arthralgias, vitamin B12 deficiency, interstitial kidney disease and biliary cirrhosis. The serological picture did not differ significantly from that observed in pSS alone.

Conclusion. Although rare, IBM may be seen in patients with pSS and it affects predominantly women. The clinical and pathological pictures do not differ from those observed in idiopathic IBM. A common autoimmune pathway in these two diseases, but no definite conclusions can be drawn.

KEY WORDS: Sjögren's syndrome, Inclusion body myositis, Anti-ro/SSA, Anti-La/SSB.

Correspondence to: A. G. Tzioufas, Department of Pathophysiology, School of Medicine, University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.